Literature DB >> 18313432

Complementary and alternative medicine and the management of the metabolic syndrome.

Jason M Hollander1, Jeffrey I Mechanick.   

Abstract

More than one third of the population has the metabolic syndrome. Although aspects of the metabolic syndrome (MSDR) are readily treatable with evidence-based interventions, many patients and practitioners are looking for alternatives to pills and injectables. Complementary and alternative medicine may offer patients safe and effective options to target components of MSDR. This review covers the definition, pathophysiology, epidemiology, and population-based consequences of MSDR, defines complementary and alternative medicine, and applies evidence-based principles to the discussion of a number of alternative therapies purported to treat aspects of MSDR. It is time that the medical community becomes familiar with current fads in dietary supplements and nutraceuticals and begins to use the descriptors proven vs unproven in reference to alternative therapies. The proven alternative therapies discussed herein can provide a starting point for patients to gain ownership of their disease and to make positive choices into the future to halt the effects of MSDR.

Entities:  

Mesh:

Year:  2008        PMID: 18313432     DOI: 10.1016/j.jada.2007.12.007

Source DB:  PubMed          Journal:  J Am Diet Assoc        ISSN: 0002-8223


  7 in total

1.  Xanthohumol improves dysfunctional glucose and lipid metabolism in diet-induced obese C57BL/6J mice.

Authors:  Cristobal L Miranda; Valerie D Elias; Joshua J Hay; Jaewoo Choi; Ralph L Reed; Jan F Stevens
Journal:  Arch Biochem Biophys       Date:  2016-03-11       Impact factor: 4.013

2.  Anthocyanidins-enriched bilberry extracts inhibit 3T3-L1 adipocyte differentiation via the insulin pathway.

Authors:  Rieko Suzuki; Masami Tanaka; Masakatsu Takanashi; Aashiq Hussain; Bo Yuan; Hiroo Toyoda; Masahiko Kuroda
Journal:  Nutr Metab (Lond)       Date:  2011-03-08       Impact factor: 4.169

3.  Edible Bird's Nest Prevents High Fat Diet-Induced Insulin Resistance in Rats.

Authors:  Zhang Yida; Mustapha Umar Imam; Maznah Ismail; Der-Jiun Ooi; Nadarajan Sarega; Nur Hanisah Azmi; Norsharina Ismail; Kim Wei Chan; Zhiping Hou; Norhayati Binti Yusuf
Journal:  J Diabetes Res       Date:  2015-07-27       Impact factor: 4.011

4.  N-Acetylneuraminic Acid Supplementation Prevents High Fat Diet-Induced Insulin Resistance in Rats through Transcriptional and Nontranscriptional Mechanisms.

Authors:  Zhang Yida; Mustapha Umar Imam; Maznah Ismail; Norsharina Ismail; Nur Hanisah Azmi; Waiteng Wong; Hadiza Altine Adamu; Nur Diyana Md Zamri; Aini Ideris; Maizaton Atmadini Abdullah
Journal:  Biomed Res Int       Date:  2015-11-25       Impact factor: 3.411

5.  Towards polypharmacokinetics: pharmacokinetics of multicomponent drugs and herbal medicines using a metabolomics approach.

Authors:  Ke Lan; Guoxiang Xie; Wei Jia
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-14       Impact factor: 2.629

6.  High fat diet-induced inflammation and oxidative stress are attenuated by N-acetylneuraminic acid in rats.

Authors:  Zhang Yida; Mustapha Umar Imam; Maznah Ismail; Norsharina Ismail; Aini Ideris; Maizaton Atmadini Abdullah
Journal:  J Biomed Sci       Date:  2015-10-24       Impact factor: 8.410

7.  Non-estrogenic Xanthohumol Derivatives Mitigate Insulin Resistance and Cognitive Impairment in High-Fat Diet-induced Obese Mice.

Authors:  Cristobal L Miranda; Lance A Johnson; Oriane de Montgolfier; Valerie D Elias; Lea S Ullrich; Joshua J Hay; Ines L Paraiso; Jaewoo Choi; Ralph L Reed; Johana S Revel; Chrissa Kioussi; Gerd Bobe; Urszula T Iwaniec; Russell T Turner; Benita S Katzenellenbogen; John A Katzenellenbogen; Paul R Blakemore; Adrian F Gombart; Claudia S Maier; Jacob Raber; Jan F Stevens
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.